Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chelsea McLean

9PUBLICATIONS

84CO-AUTHORS

Innate immunityEnvironmental epidemiologyModels of care and place of birthEpidemiological methodsPanel data analysis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Apr 13, 2026

A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study.

Nina Hertoghs, Chan Tang, Vitalija van Paassen

|Feb 26, 2026

Immunogenicity and Safety of the ExPEC9V <i>Escherichia coli</i> Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.

Isabel Leroux-Roels, Tracey A Day, Sofie Deleu

|Sep 08, 2025

Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.

Julien Nyombayire, Rosine Ingabire, Amelia Mazzei

|Apr 02, 2025

Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah

|Aug 29, 2024

Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.

Edward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo

|Sep 06, 2023

Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.

Ynke Larivière, Irene Garcia-Fogeda, Trésor Zola Matuvanga

Pageof 2

Frequent Collaborators

2 joint publications

Salo N Ooft

2 joint publications

Auguste Gaddah

2 joint publications

Emile Voest

1 joint publications

Fleur Weeber

1 joint publications

Krijn K Dijkstra

1 joint publications

Erik van Werkhoven

1 joint publications

Joris van de Haar

1 joint publications

Petur Snaebjornsson

1 joint publications

Roland Zahn

1 joint publications

Michelle Klein

Frequent Collaborators

2 joint publications

Salo N Ooft

2 joint publications

Auguste Gaddah

2 joint publications

Emile Voest

1 joint publications

Fleur Weeber

Top Related Videos

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on : Nov 01, 2011

See more related videos

Top Related Videos

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on : Nov 01, 2011

See more related videos